| pubmed-article:12399235 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12399235 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12399235 | lifeskim:mentions | umls-concept:C0019167 | lld:lifeskim |
| pubmed-article:12399235 | lifeskim:mentions | umls-concept:C0524909 | lld:lifeskim |
| pubmed-article:12399235 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:12399235 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:12399235 | pubmed:dateCreated | 2002-10-25 | lld:pubmed |
| pubmed-article:12399235 | pubmed:abstractText | Lamivudine-induced hepatitis B e antigen (HBeAg) seroconversion in patients with chronic hepatitis B was reported to be durable by several studies but controversy still exists. The aim of this study was to evaluate the durability of the responses of lamivudine treatment. | lld:pubmed |
| pubmed-article:12399235 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12399235 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12399235 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12399235 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12399235 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12399235 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12399235 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12399235 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12399235 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12399235 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:12399235 | pubmed:issn | 0168-8278 | lld:pubmed |
| pubmed-article:12399235 | pubmed:author | pubmed-author:LiaoChun-AnnC... | lld:pubmed |
| pubmed-article:12399235 | pubmed:author | pubmed-author:LeeChuan-MoCM | lld:pubmed |
| pubmed-article:12399235 | pubmed:author | pubmed-author:LuSheng-NanSN | lld:pubmed |
| pubmed-article:12399235 | pubmed:author | pubmed-author:ChangchienChi... | lld:pubmed |
| pubmed-article:12399235 | pubmed:author | pubmed-author:WangJing-Houn... | lld:pubmed |
| pubmed-article:12399235 | pubmed:author | pubmed-author:OngGuan-YeowG... | lld:pubmed |
| pubmed-article:12399235 | pubmed:author | pubmed-author:ChenTsung-Min... | lld:pubmed |
| pubmed-article:12399235 | pubmed:author | pubmed-author:TungHung-DaHD | lld:pubmed |
| pubmed-article:12399235 | pubmed:copyrightInfo | Copyright 2002 European Association for the Study of the Liver | lld:pubmed |
| pubmed-article:12399235 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12399235 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:12399235 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12399235 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12399235 | pubmed:pagination | 669-74 | lld:pubmed |
| pubmed-article:12399235 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:meshHeading | pubmed-meshheading:12399235... | lld:pubmed |
| pubmed-article:12399235 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12399235 | pubmed:articleTitle | Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation. | lld:pubmed |
| pubmed-article:12399235 | pubmed:affiliation | Liver Unit, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. chmolee@ms15.hinet.net | lld:pubmed |
| pubmed-article:12399235 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12399235 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12399235 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12399235 | lld:pubmed |
